Close
Novotech
Jabsco PureFlo 21 Single Use

News

AbbVie Secures $745M Haisco Deal to Expand Pain Drug Pipeline

AbbVie has entered into a global licensing agreement with China-based Haisco Pharmaceutical valued at up to $715 million, aiming to strengthen its presence in pain therapeutics. The Haisco deal grants AbbVie exclusive rights to develop, manufacture, and commercialize multiple...

Aragen ChemiSHE Lab Launch Strengthens Women in Pharma R&D

Aragen has introduced ChemiSHE, positioning it as India’s first chemistry synthesis laboratory fully operated and led by women scientists. The facility was inaugurated on 8 April 2026 at the company’s Mallapur campus in Hyderabad, marking a targeted step by...

Novo Nordisk OpenAI Partnership Accelerates Drug Development

Danish pharmaceutical major Novo Nordisk has entered into a strategic collaboration with OpenAI to embed artificial intelligence across its drug development operations, with the stated goal of accelerating the delivery of new treatments. Announced on Tuesday, the initiative is...

Are Pharma Grade Supplement Powders Produced Differently than Food Grade?

The supplement industry has experienced exponential growth over the past decade, with consumers becoming increasingly discerning about the quality and purity of the products they consume. As nutritional supplements have evolved from niche products to mainstream health essentials, questions...

Understanding Bacterial Infections: Causes, Signs, and Care

Bacterial infections are a very common, neglected health concern which can go unnoticed in early stages and affect people of all ages. The immune system plays an important role in identifying harmful pathogens, defending the body against invasion, and...

Tubilux Pharma Upgrades with Steriline Aseptic Filling Line

Steriline has completed the delivery and installation of a fully integrated aseptic filling line at a manufacturing facility operated by Tubilux Pharma. The system is designed to process both plastic and glass vials, supporting applications ranging from eye drops...

Regeneron Telix Radiopharma Deal Targets Cancer Therapies

Regeneron Pharmaceuticals has entered into a strategic agreement with Telix Pharmaceuticals to jointly develop next-generation oncology treatments, in a deal valued at up to $2.1 billion in milestone payments. The radiopharma collaboration will combine Regeneron’s antibody-based discovery capabilities with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »